Jun Yamamura

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

Hiroko Masuda, Norikazu Masuda, Yoshinori Kodama et al. · Cancer Chemotherapy and Pharmacology · 2010 · 75 citations

Surgical Oncology, Oncology, Breast Oncology +6

mRNA expression level of estrogen‐inducible gene, α1‐antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers

Jun Yamamura, Yasuo Miyoshi, Yasuhiro Tamaki et al. · Cancer Science · 2004 · 44 citations · Full text

Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk

Yasuo Miyoshi, Akiko Ando, S. Hasegawa et al. · European Journal of Cancer · 2003 · 42 citations

Breast Oncology, Cancer Risk, Cancer Epidemiology +12

The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast Cancer

Jun Yamamura, Shunji Kamigaki, Junya Fujita et al. · In Vivo · 2018 · 42 citations · Full text

Male Breast Cancer Originating in an Accessory Mammary Gland in the Axilla: A Case Report

Jun Yamamura, Norikazu Masuda, Yoshinori Kodama et al. · Case Reports in Medicine · 2012 · 34 citations · Full text

Surgical Oncology, Tumoral Pathology, Accessory Mammary Gland +14